IFO
ABBV icon

Independent Family Office’s AbbVie ABBV Stock Holding History

Independent Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252K Hold
1,157
– – 0.1% 82
2025
Q4 		$264K Hold
1,157
– – 0.11% 71
2025
Q3 		$268K Hold
1,157
– – 0.11% 69
2025
Q2 		$215K Buy
+1,157
New +$215K 0.1% 75

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Independent Family Office's ABBV Position: Q1 2026 in Review

Independent Family Office held its AbbVie (ABBV) position steady in Q1 2026 at 1,157 shares worth $252K. The position accounts for 0.1% of the portfolio, ranked #82.

Independent Family Office first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. The position peaked at $268K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Independent Family Office held 1,157 shares of AbbVie worth $252K as of Q1 2026.
  • Independent Family Office left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.1% of Independent Family Office's portfolio in Q1 2026, its #82 holding.
  • Independent Family Office first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • Independent Family Office's AbbVie position peaked at $268K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Independent Family Office's 13F filing for Q1 2026, filed 15 May 2026.